Yogiraj Ray
Overview
Explore the profile of Yogiraj Ray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacob L, Basu A, Paul D, Ray Y, Begam N, John C
Lancet Infect Dis
. 2024 Aug;
24(9):e601.
PMID: 39179342
No abstract available.
2.
Lodha S, Biswas S, Basu A, Pal N, Das B, Ray Y
J Assoc Physicians India
. 2024 Aug;
72(8):83-85.
PMID: 39163074
Mycetoma is a chronic skin and subcutaneous tissue infection characterized by a triad of localized swelling, draining sinuses, and grains or granules (composed of aggregations of the causative organism) within...
3.
Mehta P, Chattopadhyay P, Mohite R, DRozario R, Bandopadhyay P, Sarif J, et al.
Life Sci Alliance
. 2023 Nov;
7(1).
PMID: 37918965
Understanding the dynamic changes in gene expression during Acute Respiratory Distress Syndrome (ARDS) progression in post-acute infection patients is crucial for unraveling the underlying mechanisms. Study investigates the longitudinal changes...
4.
Kumar G, Bhalla A, Mukherjee A, Turuk A, Talukdar A, Mukherjee S, et al.
BMJ Glob Health
. 2023 Oct;
8(10).
PMID: 37816536
Introduction: The effects of COVID-19 infection persist beyond the active phase. Comprehensive description and analysis of the post COVID sequelae in various population groups are critical to minimise the long-term...
5.
Talukdar D, Bandopadhyay P, Ray Y, Paul S, Sarif J, DRozario R, et al.
Gut Pathog
. 2023 May;
15(1):22.
PMID: 37161621
Background: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation....
6.
DRozario R, Raychaudhuri D, Bandopadhyay P, Sarif J, Mehta P, Liu C, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851762
Severe COVID-19 frequently features a systemic deluge of cytokines. Circulating cytokines that can stratify risks are useful for more effective triage and management. Here, we ran a machine-learning algorithm on...
7.
Raychaudhuri D, Bandopadhyay P, DRozario R, Sarif J, Ray Y, Paul S, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2022 Sep;
6(6):511-524.
PMID: 36117954
Objective: To assess the clinical and immunological benefits of passive immunization using convalescent plasma therapy (CPT). Materials And Methods: A series of subclass analyses were performed on the previously published...
8.
Park H, Tarpey T, Liu M, Goldfeld K, Wu Y, Wu D, et al.
JAMA Netw Open
. 2022 Jan;
5(1):e2147375.
PMID: 35076698
Importance: Identifying which patients with COVID-19 are likely to benefit from COVID-19 convalescent plasma (CCP) treatment may have a large public health impact. Objective: To develop an index for predicting...
9.
Ray Y, Paul S, Bandopadhyay P, DRozario R, Sarif J, Raychaudhuri D, et al.
Nat Commun
. 2022 Jan;
13(1):383.
PMID: 35046397
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of passive immunization using convalescent...
10.
Sarif J, Raychaudhuri D, DRozario R, Bandopadhyay P, Singh P, Mehta P, et al.
Front Immunol
. 2021 Nov;
12:738093.
PMID: 34777349
Disease caused by SARS-CoV-2 coronavirus (COVID-19) led to significant morbidity and mortality worldwide. A systemic hyper-inflammation characterizes severe COVID-19 disease, often associated with acute respiratory distress syndrome (ARDS). Blood biomarkers...